Interestingly, the delivery of RNA interference of MBD1 into pancreatic cancer cells in vitro by poly(d,l-lactic-co-glycolic acid) (PLGA)-poloxamer nanoparticles had been tested and showed a good therapeutic effect [21]. This evidence concerns the gene MBD1 and familial pancreatic carcinoma.